FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140804934> ?p ?o ?g. }

• W2140804934 abstract "Hypovitaminosis D (serum 25-OHD < 30 ng/mL) is common in patients with chronic kidney disease (CKD). Vitamin D is believed to involve in the regulation of renin-angiotensin system and may be renoprotective.To compare the effects of calcium with or without calcitriol on renal function in patients with CKD.A prospective randomized trial was performed involving patients with stages 2-4 CKD and hypovitaminosis D. Baseline demographics data were taken at baseline. Patients were randomized equally into oral calcitriol plus calcium carbonate (calcitriol group) or calcium carbonate alone (non-calcitriol group). Serum levels of 25-hydroxyvitamin D (25-OHD), 1,25-dihydroxyvitamin D3 (1,25-(OH)2D), creatinine, calcium and urine protein creatinine index (uPCI) were measured at 6 and 12 weeks.Fifty (21 Female: 29 Male) patients with CKD with a median age of 53 (22-65) years were recruited. Their median MDRD eGFR (modification of diet in renal disease, estimation of glomerular filtration rate) was 36.0 (15-89) mL/min/1.73 m(2) with the CKD stage 2 (n = 8, 16%), stage 3 (n = 29, 58%), and stage 4 (n = 13, 26%) respectively. In both study groups serum 25-OHD levels were increased at 12 weeks (P = 0.001), in contrast to serum 1,25-(OH)2D levels which remained unchanged (P > 0.05), serum creatinine and uPCI were also remained unchanged until the end of study (P > 0.05 each). Patients with diabetes had higher serum creatinine (P = 0.01) and lower serum 1,25-(OH)2D (P = 0.02) at baseline. Regardless of the diabetics status, the serum 25-OHD was increased, and 1,25-(OH)2D remained unchanged at 12 weeks in both study groups. At 12 weeks, serum creatinine was decreased in patients with diabetes in the noncalcitriol group (P = 0.03) compared to stabilization of creatinine in the calcitriol group (P > 0.05). Serum calcium was increased, though it was still within the normal range in the calcitriol group (P < 0.001); whereas, in the noncalcitriol group, there was an initial reduction but increased back to baseline (P = 0.007). Urine PCI remained unchanged in both groups.We have demonstrated that calcitriol supplementation did not offer any additional benefit to reduce 25-OHD and 1,25-(OH)2D levels over calcium carbonate alone in patients with CKD in this short term study. Overall renal function remained unchanged. However, we found that calcitriol at 0.5 mg daily plus calcium carbonate 500 mg daily could be reno-protective in diabetic nephropathy regardless of their serum 25-OHD levels." @default.
• W2140804934 created "2016-06-24" @default.
• W2140804934 creator A5011598020 @default.
• W2140804934 creator A5029971471 @default.
• W2140804934 creator A5032294161 @default.
• W2140804934 creator A5043754307 @default.
• W2140804934 creator A5055186508 @default.
• W2140804934 creator A5060638343 @default.
• W2140804934 creator A5066146943 @default.
• W2140804934 creator A5069283684 @default.
• W2140804934 creator A5073666998 @default.
• W2140804934 date "2014-01-08" @default.
• W2140804934 modified "2023-10-01" @default.
• W2140804934 title "The Effect of Calcium With or Without Calcitriol Supplementation on Renal Function in Patients With Hypovitaminosis D and Chronic Kidney Disease" @default.
• W2140804934 cites W1963739971 @default.
• W2140804934 cites W1966856654 @default.
• W2140804934 cites W1975446158 @default.
• W2140804934 cites W1976998579 @default.
• W2140804934 cites W1987087271 @default.
• W2140804934 cites W1998092234 @default.
• W2140804934 cites W2005712980 @default.
• W2140804934 cites W2006060709 @default.
• W2140804934 cites W2008910933 @default.
• W2140804934 cites W2017041470 @default.
• W2140804934 cites W2018240571 @default.
• W2140804934 cites W2018503603 @default.
• W2140804934 cites W2035171429 @default.
• W2140804934 cites W2040904881 @default.
• W2140804934 cites W2045349739 @default.
• W2140804934 cites W2048596181 @default.
• W2140804934 cites W2060206383 @default.
• W2140804934 cites W2066853897 @default.
• W2140804934 cites W2083487446 @default.
• W2140804934 cites W2107072401 @default.
• W2140804934 cites W2119846536 @default.
• W2140804934 cites W2129096360 @default.
• W2140804934 cites W2131048848 @default.
• W2140804934 cites W2135527465 @default.
• W2140804934 cites W2136313468 @default.
• W2140804934 cites W2141976681 @default.
• W2140804934 cites W2149500157 @default.
• W2140804934 cites W2162129240 @default.
• W2140804934 cites W2164148172 @default.
• W2140804934 doi "https://doi.org/10.5812/numonthly.13381" @default.
• W2140804934 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3968961" @default.
• W2140804934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24719814" @default.
• W2140804934 hasPublicationYear "2014" @default.
• W2140804934 type Work @default.
• W2140804934 sameAs 2140804934 @default.
• W2140804934 citedByCount "11" @default.
• W2140804934 countsByYear W21408049342015 @default.
• W2140804934 countsByYear W21408049342017 @default.
• W2140804934 countsByYear W21408049342019 @default.
• W2140804934 countsByYear W21408049342021 @default.
• W2140804934 countsByYear W21408049342022 @default.
• W2140804934 crossrefType "journal-article" @default.
• W2140804934 hasAuthorship W2140804934A5011598020 @default.
• W2140804934 hasAuthorship W2140804934A5029971471 @default.
• W2140804934 hasAuthorship W2140804934A5032294161 @default.
• W2140804934 hasAuthorship W2140804934A5043754307 @default.
• W2140804934 hasAuthorship W2140804934A5055186508 @default.
• W2140804934 hasAuthorship W2140804934A5060638343 @default.
• W2140804934 hasAuthorship W2140804934A5066146943 @default.
• W2140804934 hasAuthorship W2140804934A5069283684 @default.
• W2140804934 hasAuthorship W2140804934A5073666998 @default.
• W2140804934 hasBestOaLocation W21408049341 @default.
• W2140804934 hasConcept C124490489 @default.
• W2140804934 hasConcept C126322002 @default.
• W2140804934 hasConcept C126894567 @default.
• W2140804934 hasConcept C134018914 @default.
• W2140804934 hasConcept C159641895 @default.
• W2140804934 hasConcept C2776079296 @default.
• W2140804934 hasConcept C2778653478 @default.
• W2140804934 hasConcept C2779740938 @default.
• W2140804934 hasConcept C2780306776 @default.
• W2140804934 hasConcept C71924100 @default.
• W2140804934 hasConcept C90924648 @default.
• W2140804934 hasConceptScore W2140804934C124490489 @default.
• W2140804934 hasConceptScore W2140804934C126322002 @default.
• W2140804934 hasConceptScore W2140804934C126894567 @default.
• W2140804934 hasConceptScore W2140804934C134018914 @default.
• W2140804934 hasConceptScore W2140804934C159641895 @default.
• W2140804934 hasConceptScore W2140804934C2776079296 @default.
• W2140804934 hasConceptScore W2140804934C2778653478 @default.
• W2140804934 hasConceptScore W2140804934C2779740938 @default.
• W2140804934 hasConceptScore W2140804934C2780306776 @default.
• W2140804934 hasConceptScore W2140804934C71924100 @default.
• W2140804934 hasConceptScore W2140804934C90924648 @default.
• W2140804934 hasIssue "1" @default.
• W2140804934 hasLocation W21408049341 @default.
• W2140804934 hasLocation W21408049342 @default.
• W2140804934 hasLocation W21408049343 @default.
• W2140804934 hasLocation W21408049344 @default.
• W2140804934 hasOpenAccess W2140804934 @default.
• W2140804934 hasPrimaryLocation W21408049341 @default.
• W2140804934 hasRelatedWork W2013152947 @default.
• W2140804934 hasRelatedWork W2034835366 @default.
• W2140804934 hasRelatedWork W2036053574 @default.
• W2140804934 hasRelatedWork W2124543160 @default.
• W2140804934 hasRelatedWork W2140445493 @default.

• next